ARCHIVES

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

This article is from The Cancer Letter archive.

Vol. 23 No. 32 | August 15, 1997

Download PDF Visit The Full Archive

Related Articles

Schmidt Approve NCAB Authorizations

February 18, 1977

Delayed Prostate Cancer Surgery Poses No Increased Risk For Some Patients

February 24, 2006

From One Competitive Market to Another: UC San Diego Stakes A Claim in Las Vegas

January 27, 2012

Study Finds Short Term Tests Predict Carcinogenicity

April 25, 1980

Separation Will Make Interaction Easier; AACR President Says

June 26, 1992

Michael Atkins Named Deputy Director at Georgetown Lombardi Cancer Center

March 2, 2012